Knights Of Columbus Asset Advisors LLC Denali Therapeutics Inc. Transaction History
Knights Of Columbus Asset Advisors LLC
- $1.4 Billion
- Q1 2025
A detailed history of Knights Of Columbus Asset Advisors LLC transactions in Denali Therapeutics Inc. stock. As of the latest transaction made, Knights Of Columbus Asset Advisors LLC holds 40,275 shares of DNLI stock, worth $589,626. This represents 0.04% of its overall portfolio holdings.
Number of Shares
40,275
Previous 39,217
2.7%
Holding current value
$589,626
Previous $799,000
31.54%
% of portfolio
0.04%
Previous 0.05%
Shares
8 transactions
Others Institutions Holding DNLI
# of Institutions
234Shares Held
127MCall Options Held
37.3KPut Options Held
7.9K-
Black Rock Inc. New York, NY13.2MShares$193 Million0.01% of portfolio
-
Baillie Gifford & CO12.1MShares$177 Million0.15% of portfolio
-
Vanguard Group Inc Valley Forge, PA11.8MShares$173 Million0.0% of portfolio
-
Wellington Management Group LLP Boston, MA11.4MShares$167 Million0.03% of portfolio
-
Ubs Asset Management Americas Inc Chicago, IL6.77MShares$99.1 Million0.02% of portfolio
About Denali Therapeutics Inc.
- Ticker DNLI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 134,174,000
- Market Cap $1.96B
- Description
- Denali Therapeutics Inc., a biopharmaceutical company, discovers and develops therapeutic candidates for neurodegenerative diseases in the United States. It offers leucine-rich repeat kinase 2 (LRRK2) inhibitor product candidate, including BIIB122/DNL151, a small molecule inhibitor, which is in phase I and phase Ib clinical trials for the treatm...